Evidence map›Paper›PMID 29882606›Full record

ArticleHuman psychopharmacology2018

Why meta is better: A reply to Linden-Carmichael et al. (2018).

Andrew Scholey, Sarah Benson, Sean Johnson, Chris Alford, Samuel Benrejeb Godefroy, Joris C Verster

Abstract readComment
In one paragraph

Article in Human psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Andrew ScholeyCentre for Human Psychopharmacology, Swinburne University, Melbourne, Australia.ORCID 0000-0003-4484-5462
Sarah BensonCentre for Human Psychopharmacology, Swinburne University, Melbourne, Australia.ORCID 0000-0001-8626-0521
Sean JohnsonPsychological Sciences Research Group, University of the West of England, Bristol.ORCID 0000-0002-0893-5578
Chris AlfordPsychological Sciences Research Group, University of the West of England, Bristol.ORCID 0000-0003-0887-6958
Samuel Benrejeb GodefroyDepartment of Food Sciences, Food Risk Analysis and Regulatory Excellence Platform (FRAREP), Institute of Nutrition and Functional foods (INAF), Université Laval, QC, Canada.
Joris C VersterCentre for Human Psychopharmacology, Swinburne University, Melbourne, Australia.ORCID 0000-0002-6455-2096

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Energy DrinksAlcoholic BeveragesHumans

Identifiers

PMID29882606
PMCPMC6055816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.